Euan Posted October 1, 2011 Share Posted October 1, 2011 Alpharadin (radium-223 chloride) was found to improve overall survival by patients with CRPC (castration-resistant prostate cancer) and symptomatic bone metastases - survival rates improved by 44%. For the full copyright article see http://www.medicalne...cles/234945.php Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.